Dr. Zandberg on the Role of Immunotherapy in Head and Neck Cancer – OncLive
|
Dr. Zandberg on the Role of Immunotherapy in Head and Neck Cancer
OncLive With immunotherapy, these single agents are being combined with targeted agents and with other immunotherapy agents, including durvalumab (Imfinzi), in an effort to enhance the amount of patients who benefit from immunotherapy, says Zandberg. |
